Detalhe da pesquisa
1.
IMPDH1/YB-1 Positive Feedback Loop Assembles Cytoophidia and Represents a Therapeutic Target in Metastatic Tumors.
Mol Ther
; 28(5): 1299-1313, 2020 05 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32209435
2.
Long noncoding RNA SNHG12 indicates the prognosis of prostate cancer and accelerates tumorigenesis via sponging miR-133b.
J Cell Physiol
; 235(2): 1235-1246, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31267540
3.
The Identification of Key Gene Expression Signature in Prostate Cancer.
Crit Rev Eukaryot Gene Expr
; 30(2): 153-168, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32558494
4.
High expression of TAZ serves as a novel prognostic biomarker and drives cancer progression in renal cancer.
Exp Cell Res
; 376(2): 181-191, 2019 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30731073
5.
Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance.
Cancer Sci
; 110(1): 86-98, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30320939
6.
Melatonin/PGC1A/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning.
J Pineal Res
; 67(4): e12607, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31469445
7.
RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.
Exp Cell Res
; 372(2): 118-128, 2018 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30267660
8.
MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint.
Cell Physiol Biochem
; 48(2): 801-814, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30032144
9.
Upregulation of MIAT Regulates LOXL2 Expression by Competitively Binding MiR-29c in Clear Cell Renal Cell Carcinoma.
Cell Physiol Biochem
; 48(3): 1075-1087, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30041179
10.
Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
BMC Cancer
; 18(1): 88, 2018 01 22.
Artigo
Inglês
| MEDLINE | ID: mdl-29357836
11.
Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma.
Exp Cell Res
; 358(2): 269-278, 2017 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28684115
12.
Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.
Cell Physiol Biochem
; 43(6): 2420-2433, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29073615
13.
Diagnostic and prognostic value of scavenger receptor class B type 1 in clear cell renal cell carcinoma.
Tumour Biol
; 39(5): 1010428317699110, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28466781
14.
Corrigendum to "Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma" [Exp. Cell Res. (2017) 269-278].
Exp Cell Res
; 362(1): 244, 2018 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29174910
15.
Endoscopic excision versus radical nephroureterectomy for non-muscle invasive upper tract urothelial carcinoma: A population-based large cohort study.
Heliyon
; 9(12): e22408, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38107280
16.
Overall survival and cancer-specific survival were improved in local treatment of metastatic prostate cancer.
Front Oncol
; 13: 1130680, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37207146
17.
Epigenetic differences in NCOA2: a novel biomarker that predicts prognosis in clear cell renal cell carcinoma.
Am J Transl Res
; 15(4): 2515-2527, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37193192
18.
Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression.
Aging Dis
; 14(5): 1757-1774, 2023 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37196108
19.
Causes of Death Among Prostate Cancer Patients Aged 40 Years and Older in the United States.
Front Oncol
; 12: 914875, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35847902
20.
Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1-Mediated Immune Evasion in Prostate Cancer.
Cancer Immunol Res
; 9(7): 838-852, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34011528